Medtech 360

December 2013

Global Markets for Urinary Incontinence Devices 2014

Introduction:

The global UI device market will experience robust growth through 2022 despite regional differences in market dynamics. Greater access to health care in the BRIC countries, increasingly well-trained and better-informed physicians, as well as the adoption of newer devices will be primary drivers of this market overall.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for UI devices in the US, Europe, and BRIC across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   The global UI device market is poised for growth over the forecast period, with strong opportunities for growth in the developing BRIC region in particular.

Which segments still present room for innovation and product development?

Which competitors are in a position to benefit from these opportunities?

  *   Intermittent catheters are becoming increasingly preferred due to their clinical benefits compared to other types of urinary catheters.

Within the intermittent catheter segment, which types of catheters will be most favored?

How will this impact the adoption of Foley catheters in different geographies?

  *   Market penetration of the different types of vaginal slings will change significantly over the forecast period within each region covered in this report.

Which type of vaginal sling will experience the strongest growth?

To what extent will traditional treatment methods impact this market’s growth?

Scope:

Geographies Covered: US, Europe (Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, UK), Brazil, Russia, India, China

Procedures Covered: Millennium Research Group's analysis uses the following breakdown of procedures:

Procedure Type

Vaginal Sling Procedures

Material

Commercial Mesh

Autologous Mesh*

Male Sling Procedures

AUS Procedures**

UBA Treatments***

Notes: (1) *Autologous mesh vaginal sling procedures do not include those performed in the US. (2) **Male sling and AUS procedures only include those performed in the US. (3) ***UBA treatments only include those performed in the US, France, Germany, Italy, Spain, and the UK.

Products Covered: Millennium Research Group's analysis uses the following breakdown of products in the market:

Product Type

Urinary Catheters

Product Type

Intermittent Catheters

Product Subtype

Strips

Product Feature

Coated*

Uncoated*

Closed Systems

Product Feature

Coated*

Uncoated**

Trays

Product Feature

Coated**

Uncoated**

Foley Catheters***

Product Subtype

Trays

Material

Latex

Product Feature

Coated**

Uncoated**

Silicone

Product Feature

Coated**

Uncoated**

Strips

Material

Latex

Product Feature

Coated**

Uncoated**

Silicone

Product Feature

Coated**

Uncoated**

MECs

Material

Latex*

Nonlatex*

Urine Drainage Bags

Product Type

Leg Bags*

Bedside Bags*

Vaginal Slings

Product Type

TOT

Single-Incision

Other†

Male Slings**

AUSs**

UBAs‡

(1) *Only discussed qualitatively for the BRIC region. (2) **Only covered in the US. (3) ***Foley catheters are not further segmented for Europe and the BRIC region. (4) †Other includes retropubic, suprapubic, and prepubic vaginal slings. (5) ‡UBAs are only covered for the US, France, Germany, Italy, Spain, and the UK.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Lexie Code, M.Ed.
Jason R. Lau, M.A.
Jennifer Smith

Contributors
Simon Andrews
April Chan
Samuli Heilala, M.Sc.
Nancy Huynh



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • 3L
  • Aesculap
  • Allergan
  • AMS
  • Amsino
  • Baxter
  • B. Braun
  • BioDerm
  • Boston Scientific
  • Caldera Medical
  • Cardinal Health
  • CL MĂ©dical
  • Coloplast
  • Contura
  • ConvaTec
  • Cook Medical
  • CooperSurgical
  • Cousin Biotech
  • Covidien
  • C. R. Bard
  • DENTSPLY International
  • Endo Health Solutions
  • Ethicon
  • Euromedical
  • Gallini Medical Devices
  • Herniamesh
  • Hollister
  • Hunter Urology
  • Manfred Sauer
  • Medasil
  • Medline Industries
  • Merz Pharma
  • Neomedic International
  • Novo Nordisk
  • polymed
  • Promedon
  • Q-Med
  • Rochester Medical
  • Romsons
  • SERAG-WIESSNER
  • Teleflex Medical
  • Urocare Products
  • Uroplasty
  • Wellspect HealthCare
Decision Resources Group brands include: